NYSE:OGEN
Oragenics Inc Stock News
$1.02
-0.0150 (-1.45%)
At Close: May 01, 2024
Oragenics, Inc. to Present at the BIO Investor Forum
12:00pm, Tuesday, 22'nd Oct 2019
Oragenics, Inc. (NYSE American:OGEN), a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis (OM), today announced it will be presenting
OGEN: Phase 2 Trial of AG013 More Than 2/3rd Enrolled…
12:15pm, Wednesday, 02'nd Oct 2019
By David Bautz, PhD NYSE:OGEN READ THE FULL OGEN RESEARCH REPORT Business Update Poster on Phase 2 Trial of AG013 Presented at ESMO 2019 On September 30, 2019, Oragenics, Inc. (NYSE:OGEN) announced th
Oragenics Presents Interim Data on The AG013 Phase 2 Clinical Trial at the European Society for Medical Oncology Congress 2019
12:00pm, Monday, 30'th Sep 2019
Oragenics, Inc. (NYSE American:OGEN) (“Oragenics”), a leader in the development of novel antibiotics against infectious diseases and effective treatments for oral mucositis, today announces initia
The Week Ahead In Biotech (Sept. 29-Oct. 5): Conference Presentations, IPOs Hit Top Gear
12:00am, Sunday, 29'th Sep 2019Oragenics, Inc. Announces Phase 2 Clinical Trial of AG013 Reaches Enrollment of 158 Patients
12:00pm, Wednesday, 25'th Sep 2019
Oragenics, Inc. (NYSE American: OGEN), a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, today announces it has enrolled 158 patie
Oragenics, Inc. Announces Phase 2 Clinical Trial Of AG013 Reaches Enrollment Of 158 Patients
12:00am, Wednesday, 25'th Sep 2019Oragenics, Inc. to Present Interim Data on AG013 at the European Society of Medical Oncology Congress
12:00pm, Monday, 23'rd Sep 2019
Oragenics, Inc. (NYSE American:OGEN), a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis (“OM”), today announces that an abstrac
Who Has Been Buying Oragenics, Inc. (NYSEMKT:OGEN) Shares?
02:41pm, Tuesday, 10'th Sep 2019
It is not uncommon to see companies perform well in the years after insiders buy shares. On the other hand, we'd be...
Sabby Management, Llc Buys Actinium Pharmaceuticals Inc, Ampio Pharmaceuticals Inc, China Jo-Jo ...
12:00am, Tuesday, 20'th Aug 2019The Daily Biotech Pulse: Mallinkckrodt's Terlipressin, Deciphera Offering, Sellas Reboots On Earnings
12:00am, Thursday, 15'th Aug 2019Oragenics, Inc. (NYSEMKT:OGEN): What Does Its Beta Value Mean For Your Portfolio?
01:46pm, Wednesday, 10'th Jul 2019
Anyone researching Oragenics, Inc. (NYSEMKT:OGEN) might want to consider the historical volatility of the share price...
